| Indicators | Browse All

Haleon plc (HLN)

Healthcare | Drug Manufacturers - Specialty & Generic | Weybridge, United Kingdom | NYSE
10.11 USD +0.07 (0.697%) ⇧ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 10.11

Short-term:★★⯪☆☆Long-term:★★★☆☆Dividends:★★★☆☆
Hot Take | Aug. 22, 2026, 2:30 a.m. EDT

Haleon presents a compelling value proposition where the market has punished the stock for a single year of flat performance while ignoring the robust multi-year recovery. The long-term rating is solid because the business has delivered nearly 58% gains over the last three years, demonstrating resilience and growth potential that the recent stagnation does not negate. Fundamentally, the company trades at a reasonable forward P/E of 16x with healthy operating margins above 23%, suggesting the current price offers a margin of safety relative to its earnings power. The short-term outlook remains neutral due to the immediate technical pressure; the stock is currently trading below its 200-day average, and the statistical forecast model indicates a flat path for the next 45 days. However, this technical weakness creates an attractive entry point for investors willing to look past the immediate noise. The options market confirms this sentiment, with traders aggressively buying calls and ignoring puts, signaling a belief that the recent dip was a buying opportunity rather than a trend reversal. While the dividend yield is modest at 2%, it is sustainable given the low payout ratio, making this a core holding for income-focused investors who prioritize long-term capital appreciation over immediate yield.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.091218
AutoETS0.091218
AutoTheta0.091945
MSTL0.094089

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 49%
H-stat 12.12
Ljung-Box p 0.000
Jarque-Bera p 0.158
Excess Kurtosis -1.30
Attribute Value
Sector Healthcare
Ex Dividend Date 2026-08-13
Last Dividend Date 2026-08-13
Debt to Equity Ratio 50.195
Revenue per Share 2.504
Market Cap 44,459,909,120
Trailing P/E 20.22
Forward P/E 16.23
Beta 0.25
Profit Margins 14.55%
Website https://www.haleon.com

As of Aug. 22, 2026, 2:30 a.m. EDT: Speculator positioning is heavily skewed toward calls, with open interest concentrated at the money and slightly out-of-the-money strikes ($10-$12.50). Put volume is negligible compared to calls, indicating a lack of hedging demand and a speculative bias toward upside participation despite the recent price dip.


Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
0.66% 1.99% 1.86%
Dividend History
Date Dividend Yield %
2026-08-14 0.064 0.659794
2026-04-10 0.131 1.331301
2025-08-15 0.059 0.611399
2025-04-25 0.117 1.149312
2024-08-16 0.051 0.526859
2024-03-14 0.106 1.287971
2023-08-24 0.046 0.556901
2023-03-16 0.058 0.725000
Additional Data
dividendRate 0.2
dividendYield 1.97
exDividendDate 2026-08-14
trailingAnnualDividendRate 0.073
trailingAnnualDividendYield 0.0072709164
lastDividendValue 0.064
lastDividendDate 2026-08-14
dividendDate 2026-09-17

Info Dump

Attribute Value
52 Week Change 0.02868855
Address1 The Heights
Address2 Building 5, First Floor
All Time High 11.42
All Time Low 5.59
Ask 10.1
Ask Size 35,000
Average Daily Volume10 Day 7,936,470
Average Daily Volume3 Month 9,672,688
Average Volume 9,672,688
Average Volume10Days 7,936,470
Beta 0.245
Bid 10.09
Bid Size 61,600
Book Value 5.0142784
City Weybridge
Compensation As Of Epoch Date 1,767,139,200
Country United Kingdom
Crypto Tradeable 0
Currency USD
Current Price 10.11
Current Ratio 0.687
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 10.11
Day Low 10.03
Debt To Equity 50.195
Display Name Haleon
Dividend Date 1,789,603,200
Dividend Rate 0.2
Dividend Yield 1.97
Earnings Call Timestamp End 1,785,398,400
Earnings Call Timestamp Start 1,785,398,400
Earnings Growth -0.045
Earnings Quarterly Growth -0.055
Earnings Timestamp 1,785,414,600
Earnings Timestamp End 1,785,414,600
Earnings Timestamp Start 1,785,414,600
Ebitda 2,848,000,000
Ebitda Margins 0.25538
Enterprise To Ebitda 18.399
Enterprise To Revenue 4.699
Enterprise Value 52,399,673,344
Eps Current Year 0.56925
Eps Forward 0.62309
Eps Trailing Twelve Months 0.5
Esg Populated 0
Ex Dividend Date 1,786,665,600
Exchange NYQ
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 9.7516
Fifty Day Average Change 0.3583994
Fifty Day Average Change Percent 0.03675288
Fifty Two Week Change Percent 2.868855
Fifty Two Week High 11.28
Fifty Two Week High Change -1.1700001
Fifty Two Week High Change Percent -0.103723414
Fifty Two Week Low 8.65
Fifty Two Week Low Change 1.46
Fifty Two Week Low Change Percent 0.16878614
Fifty Two Week Range 8.65 - 11.28
Financial Currency GBP
First Trade Date Milliseconds 1,658,755,800,000
Float Shares 4,427,395,500
Forward Eps 0.62309
Forward P E 16.225584
Free Cashflow 1,801,750,016
Full Exchange Name NYSE
Full Time Employees 24,535
Fullday Change 0.0699997
Fullday Change Percent 0.697208
Fullday Price 10.11
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.65567
Gross Profits 7,312,000,000
Has Pre Post Market Data 1
Held Percent Insiders 0.00014
Held Percent Institutions 0.13543999
Implied Shares Outstanding 4,397,616,983
Industry Drug Manufacturers - Specialty & Generic
Industry Disp Drug Manufacturers - Specialty & Generic
Industry Key drug-manufacturers-specialty-generic
Is Earnings Date Estimate 0
Language en-US
Last Dividend Date 1,786,665,600
Last Dividend Value 0.064
Last Fiscal Year End 1,767,139,200
Long Business Summary Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc has a collaboration agreement with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global win as one strategy. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Long Name Haleon plc
Market us_market
Market Cap 44,459,909,120
Market State CLOSED
Max Age 86,400
Message Board Id finmb_1671690919
Most Recent Quarter 1,782,777,600
Net Income To Common 1,623,000,064
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 44,184,476,617
Number Of Analyst Opinions 5
Open 10.04
Operating Cashflow 2,651,000,064
Operating Margins 0.23938
Payout Ratio 0.3953
Peg Ratio 2.49
Phone 44 1932 959 500
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 10.11
Post Market Time 1,787,959,804
Previous Close 10.04
Price Eps Current Year 17.76021
Price Hint 2
Price To Book 2.0162423
Price To Sales Trailing12 Months 3.9867208
Profit Margins 0.14553
Quick Ratio 0.508
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0699997
Regular Market Change Percent 0.697208
Regular Market Day High 10.11
Regular Market Day Low 10.03
Regular Market Day Range 10.03 - 10.11
Regular Market Open 10.04
Regular Market Previous Close 10.04
Regular Market Price 10.11
Regular Market Time 1,787,947,202
Regular Market Volume 7,906,722
Return On Assets 0.050809998
Return On Equity 0.100930005
Revenue Growth 0.022
Revenue Per Share 2.504
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 4,397,616,983
Shares Percent Shares Out 0.003
Shares Short 13,303,294
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 12,630,231
Short Name Haleon plc
Short Percent Of Float 0.003
Short Ratio 1.3
Source Interval 15
Symbol HLN
Target High Price 13.77
Target Low Price 10.0
Target Mean Price 11.994
Target Median Price 12.4
Total Cash 826,000,000
Total Cash Per Share 0.186
Total Debt 8,252,000,256
Total Revenue 11,152,000,000
Tradeable 0
Trailing Annual Dividend Rate 0.073
Trailing Annual Dividend Yield 0.0072709164
Trailing Eps 0.5
Trailing P E 20.22
Trailing Peg Ratio 2.4582
Triggerable 1
Two Hundred Day Average 9.83955
Two Hundred Day Average Change 0.27044964
Two Hundred Day Average Change Percent 0.027485976
Type Disp Equity
Volume 7,906,722
Website https://www.haleon.com
Zip KT13 0NY